DANNA BARKLEY: Open Payments
NPI 1740844927 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 30 payments from 15 companies in 2025. Trend: 2023 $20 · 2024 $0 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $144 |
| Neurelis, Inc. | 4 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| CSL Behring | 2 | $48 |
| Amneal Pharmaceuticals LLC | 2 | $41 |
| Eisai Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $31 |
| Biogen, Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $26 |
Products named: Rystiggo, REXULTI, VALTOCO, KESIMPTA, Hizentra, CREXONT, Leqembi, Nayzilam.
Industry payments across AR — which companies pay providers there.
